EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
155 hedge funds and large institutions have $508M invested in Eagle Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
-11
Holders Change %
-6.63%
% of All Funds
2.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
64
Reduced
54
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
$18.8M |
| 2 |
AC
Armistice Capital
New York
|
$8.01M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$3.74M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
$66.4M |
| 5 |
Norges Bank
Oslo,
Norway
|
$3.55M |
